Search for other papers by Nicolai Preisler in
Google Scholar
PubMed
Search for other papers by Pascal Laforêt in
Google Scholar
PubMed
Search for other papers by Karen Lindhardt Madsen in
Google Scholar
PubMed
Search for other papers by Edith Husu in
Google Scholar
PubMed
Search for other papers by Christoffer Rasmus Vissing in
Google Scholar
PubMed
Search for other papers by Gitte Hedermann in
Google Scholar
PubMed
Search for other papers by Henrik Galbo in
Google Scholar
PubMed
Search for other papers by Christopher Lindberg in
Google Scholar
PubMed
Search for other papers by John Vissing in
Google Scholar
PubMed
Introduction Pompe disease (Glycogenosis type II; OMIM #232300) is caused by lysosomal acid alpha-glucosidase deficiency (EC# 3.2.1.20), which leads to a metabolic block in intra-lysosomal glycogen breakdown ( 1 ). In the late-onset forms of
Search for other papers by Annalisa Blasetti in
Google Scholar
PubMed
Search for other papers by Valeria Castorani in
Google Scholar
PubMed
Search for other papers by Nella Polidori in
Google Scholar
PubMed
Search for other papers by Ilaria Mascioli in
Google Scholar
PubMed
Search for other papers by Francesco Chiarelli in
Google Scholar
PubMed
Search for other papers by Cosimo Giannini in
Google Scholar
PubMed
Ruco L & Falaschi P . Diagnosis of hepatic glycogenosis in poorly controlled type 1 diabetes mellitus . World Journal of Diabetes 2014 5 882 – 888 . ( https://doi.org/10.4239/wjd.v5.i6.882 ) 4 Dunger DB & Cheetham TD . Growth hormone